Fulgent Genetics Inc (FLGT)
16.95
-0.33
(-1.91%)
USD |
NASDAQ |
Nov 21, 16:00
16.94
-0.02
(-0.09%)
After-Hours: 20:00
Fulgent Genetics Revenue (Quarterly): 71.74M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 71.74M |
| June 30, 2024 | 71.03M |
| March 31, 2024 | 64.48M |
| December 31, 2023 | 70.50M |
| September 30, 2023 | 84.69M |
| June 30, 2023 | 67.85M |
| March 31, 2023 | 66.17M |
| December 31, 2022 | 67.70M |
| September 30, 2022 | 105.66M |
| June 30, 2022 | 125.34M |
| March 31, 2022 | 320.27M |
| December 31, 2021 | 251.67M |
| September 30, 2021 | 227.87M |
| June 30, 2021 | 153.62M |
| March 31, 2021 | 359.43M |
| December 31, 2020 | 294.98M |
| September 30, 2020 | 101.72M |
| June 30, 2020 | 17.26M |
| March 31, 2020 | 7.753M |
| Date | Value |
|---|---|
| December 31, 2019 | 8.387M |
| September 30, 2019 | 10.35M |
| June 30, 2019 | 8.424M |
| March 31, 2019 | 5.37M |
| December 31, 2018 | 5.673M |
| September 30, 2018 | 5.625M |
| June 30, 2018 | 5.40M |
| March 31, 2018 | 4.653M |
| December 31, 2017 | 4.281M |
| September 30, 2017 | 4.503M |
| June 30, 2017 | 4.64M |
| March 31, 2017 | 5.306M |
| December 31, 2016 | 5.854M |
| September 30, 2016 | 5.011M |
| June 30, 2016 | 3.971M |
| March 31, 2016 | 3.44M |
| December 31, 2015 | 2.901M |
| September 30, 2015 | 2.905M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
7.753M
Minimum
Mar 2020
359.43M
Maximum
Mar 2021
126.91M
Average
78.22M
Median
Revenue (Quarterly) Benchmarks
| Delcath Systems Inc | 11.20M |
| Star Equity Holdings Inc | 13.66M |
| Exact Sciences Corp | 708.66M |
| CytoSorbents Corp | 8.613M |
| Progyny Inc | 286.62M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.65M |
| Total Expenses (Quarterly) | 88.82M |
| EPS Diluted (Quarterly) | -0.48 |
| Enterprise Value | 304.74M |
| Gross Profit Margin (Quarterly) | 37.32% |
| Profit Margin (Quarterly) | -20.42% |
| Earnings Yield | -32.57% |
| Normalized Earnings Yield | -8.977 |